PROTEOMIC DISSECTION OF KEAP1/NRF2 SIGNALING TO DETERMINE NEW PATHWAY INTERACTORS IN CANCER
Public DepositedAdd to collection
You do not have access to any existing collections. You may create a new collection.
Downloadable Content
Download PDFCitation
MLA
Mulvaney, Kathleen. Proteomic Dissection Of Keap1/nrf2 Signaling To Determine New Pathway Interactors In Cancer. 2016. https://doi.org/10.17615/7v3v-x224APA
Mulvaney, K. (2016). PROTEOMIC DISSECTION OF KEAP1/NRF2 SIGNALING TO DETERMINE NEW PATHWAY INTERACTORS IN CANCER. https://doi.org/10.17615/7v3v-x224Chicago
Mulvaney, Kathleen. 2016. Proteomic Dissection Of Keap1/nrf2 Signaling To Determine New Pathway Interactors In Cancer. https://doi.org/10.17615/7v3v-x224- Last Modified
- March 20, 2019
- Creator
-
Mulvaney, Kathleen
- Affiliation: School of Medicine, Department of Cell Biology and Physiology
- Abstract
- KEAP1/NRF2 signaling regulates intracellular reactive oxygen species and protects cells from reactive oxygen-induced damage. KEAP1 serves as the substrate adaptor for a CULLIN3-based E3 ubiquitin ligase (KEAP1-CUL3-RBX1). Under homeostatic conditions, the KEAP1-CUL3-RBX1 ligase targets its well-established substrate NFE2L2/NRF2 for rapid proteasomal degradation. During oxidative stress conditions, KEAP1 is inactivated, and NRF2 protein levels increase. NRF2 then drives the transcription of a battery of cytoprotective genes that ultimately mitigate the cellular stress that was sensed by KEAP1. This elegant signaling pathway has long been thought to be the primary function of the redox-sensitive KEAP1 E3 ligase complex. KEAP1/NRF2 signaling is the cell’s primary defense against reactive oxygen stress. Therefore, perturbations in this pathway are associated with a number of human pathologies, including cancer. The KEAP1/NRF2 pathway is frequently mutated in cancer, where NRF2-activating mutations correlate with disease progression and poor patient outcomes. In addition to somatic gene mutations in KEAP1, NRF2 or CUL3, we have demonstrated that NRF2 is activated at the protein level in tumors by a competitive binding method, underscoring the importance of understanding the protein-protein interactions within this pathway. Utilizing mass spectrometry-based approaches, we identified the KEAP1 protein interaction network under basal and proteasome-inhibited conditions. Coupling this screening with a candidate-based approach, MCM3 and NRF1 were identified as putative, novel KEAP1-CUL3-RBX1 substrates for ubiquitylation. MCM3, a subunit of the essential DNA replicative helicase, was validated as a KEAP1-CUL3-RBX1 substrate for ubiquitylation. We have characterized the binding and ubiquitylation of MCM3 by KEAP1 and determined that KEAP1 does not regulate MCM3 protein stability. Rather, we propose a model where KEAP1 ubiquitylates MCM3 to regulate its function within the replicative helicase. We demonstrate that KEAP1 associates with chromatin in a cell cycle-dependent fashion with kinetics similar to MCM3 and is thus poised to affect MCM3 function. We also demonstrate that loss of KEAP1 affects cell cycle progression and proliferation in normal cells. Therefore, we have found previously unappreciated roles for KEAP1 in cell cycle progression and chromatin dynamics.
- Date of publication
- December 2016
- Keyword
- DOI
- Resource type
- Rights statement
- In Copyright
- Advisor
- Vaziri, Cyrus
- Cook, Jean
- Baldwin, Albert
- Major, Michael
- Cyr, Douglas
- Mulvaney, Michael
- Degree
- Doctor of Philosophy
- Degree granting institution
- University of North Carolina at Chapel Hill Graduate School
- Graduation year
- 2016
- Language
Relations
- Parents:
This work has no parents.
Items
Thumbnail | Title | Date Uploaded | Visibility | Actions |
---|---|---|---|---|
Mulvaney_unc_0153D_16678.pdf | 2019-04-10 | Public | Download |